These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

190 related items for PubMed ID: 20410873

  • 1. The antipsychotics olanzapine, risperidone, clozapine, and haloperidol are D2-selective ex vivo but not in vitro.
    McCormick PN, Kapur S, Graff-Guerrero A, Raymond R, Nobrega JN, Wilson AA.
    Neuropsychopharmacology; 2010 Jul; 35(8):1826-35. PubMed ID: 20410873
    [Abstract] [Full Text] [Related]

  • 2. Acutely administered antipsychotic drugs are highly selective for dopamine D2 over D3 receptors.
    McCormick PN, Wilson VS, Wilson AA, Remington GJ.
    Pharmacol Res; 2013 Apr; 70(1):66-71. PubMed ID: 23327779
    [Abstract] [Full Text] [Related]

  • 3. Risperidone compared with new and reference antipsychotic drugs: in vitro and in vivo receptor binding.
    Schotte A, Janssen PF, Gommeren W, Luyten WH, Van Gompel P, Lesage AS, De Loore K, Leysen JE.
    Psychopharmacology (Berl); 1996 Mar; 124(1-2):57-73. PubMed ID: 8935801
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Occupancy of central neurotransmitter receptors by risperidone, clozapine and haloperidol, measured ex vivo by quantitative autoradiography.
    Schotte A, Janssen PF, Megens AA, Leysen JE.
    Brain Res; 1993 Dec 24; 631(2):191-202. PubMed ID: 7510574
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. In vivo receptor occupancy of NRA0045, a putative atypical antipsychotic, in rats.
    Chaki S, Funakoshi T, Yoshikawa R, Okuyama S, Kumagai T, Nakazato A, Nagamine M, Tomisawa K.
    Neuropharmacology; 1999 Aug 24; 38(8):1185-94. PubMed ID: 10462131
    [Abstract] [Full Text] [Related]

  • 10. Clinical and theoretical implications of 5-HT2 and D2 receptor occupancy of clozapine, risperidone, and olanzapine in schizophrenia.
    Kapur S, Zipursky RB, Remington G.
    Am J Psychiatry; 1999 Feb 24; 156(2):286-93. PubMed ID: 9989565
    [Abstract] [Full Text] [Related]

  • 11. Amisulpride the 'atypical' atypical antipsychotic--comparison to haloperidol, risperidone and clozapine.
    Natesan S, Reckless GE, Barlow KB, Nobrega JN, Kapur S.
    Schizophr Res; 2008 Oct 24; 105(1-3):224-35. PubMed ID: 18710798
    [Abstract] [Full Text] [Related]

  • 12. Effects of risperidone, clozapine and haloperidol on extracellular recordings of substantia nigra reticulata neurons of the rat brain.
    Bruggeman R, Westerink BH, Timmerman W.
    Eur J Pharmacol; 1997 Apr 11; 324(1):49-56. PubMed ID: 9137912
    [Abstract] [Full Text] [Related]

  • 13. The antipsychotics clozapine and olanzapine increase plasma glucose and corticosterone levels in rats: comparison with aripiprazole, ziprasidone, bifeprunox and F15063.
    Assié MB, Carilla-Durand E, Bardin L, Maraval M, Aliaga M, Malfètes N, Barbara M, Newman-Tancredi A.
    Eur J Pharmacol; 2008 Sep 11; 592(1-3):160-6. PubMed ID: 18640111
    [Abstract] [Full Text] [Related]

  • 14. Optimizing limbic selective D2/D3 receptor occupancy by risperidone: a [123I]-epidepride SPET study.
    Bressan RA, Erlandsson K, Jones HM, Mulligan RS, Ell PJ, Pilowsky LS.
    J Clin Psychopharmacol; 2003 Feb 11; 23(1):5-14. PubMed ID: 12544369
    [Abstract] [Full Text] [Related]

  • 15. Interaction of antipsychotic drugs with neurotransmitter receptor sites in vitro and in vivo in relation to pharmacological and clinical effects: role of 5HT2 receptors.
    Leysen JE, Janssen PM, Schotte A, Luyten WH, Megens AA.
    Psychopharmacology (Berl); 1993 Feb 11; 112(1 Suppl):S40-54. PubMed ID: 7530377
    [Abstract] [Full Text] [Related]

  • 16. Evaluation of dopamine D-2 receptor occupancy by clozapine, risperidone, and haloperidol in vivo in the rodent and nonhuman primate brain using 18F-fallypride.
    Mukherjee J, Christian BT, Narayanan TK, Shi B, Mantil J.
    Neuropsychopharmacology; 2001 Oct 11; 25(4):476-88. PubMed ID: 11557161
    [Abstract] [Full Text] [Related]

  • 17. Using pharmacokinetic-pharmacodynamic modelling as a tool for prediction of therapeutic effective plasma levels of antipsychotics.
    Olsen CK, Brennum LT, Kreilgaard M.
    Eur J Pharmacol; 2008 Apr 28; 584(2-3):318-27. PubMed ID: 18325493
    [Abstract] [Full Text] [Related]

  • 18. In vitro and in vivo receptor binding and effects on monoamine turnover in rat brain regions of the novel antipsychotics risperidone and ocaperidone.
    Leysen JE, Janssen PM, Gommeren W, Wynants J, Pauwels PJ, Janssen PA.
    Mol Pharmacol; 1992 Mar 28; 41(3):494-508. PubMed ID: 1372084
    [Abstract] [Full Text] [Related]

  • 19. Long-term effects of olanzapine, risperidone, and quetiapine on dopamine receptor types in regions of rat brain: implications for antipsychotic drug treatment.
    Tarazi FI, Zhang K, Baldessarini RJ.
    J Pharmacol Exp Ther; 2001 May 28; 297(2):711-7. PubMed ID: 11303062
    [Abstract] [Full Text] [Related]

  • 20. Haloperidol both prevents and reverses quinpirole-induced nonregulatory water intake, a putative animal model of psychogenic polydipsia.
    Amato D, Stasi MA, Borsini F, Nencini P.
    Psychopharmacology (Berl); 2008 Oct 28; 200(2):157-65. PubMed ID: 18597076
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.